Gns Healthcare

A company called Gene Network Sciences GNS had been founded in 2000 by Cornell physicists Colin Hill and Iya Khalil which focused on computational biology models of interactions among genes and proteins in cells with a focus on cancer drug discovery.

Gns healthcare. GNS Healthcare is a privately held data analytics company based in Cambridge Massachusetts with offices in Cambridge and Austin Texas. They focus on advancing and applying industrial-scale data analytics to empower key healthcare stakeholders to solve complex care treatment and cost challenges. GNS Healthcare offers excellent medical dental and vision insurance as well as the option for a flexible spending account for health andor dependent care expenses.

Celgene and Cigna Ventures are the most recent investors. GNS Healthcare is an AI-driven precision medicine company developing Gemini The in silico Patient models from clinico-genomic data across oncology auto-immune diseases and neurology. GNS Healthcare announces the completion of a 10M Series C financing round.

Many of the top 20 biopharma companies have used or have been using GNS for solving hard healthcare problems - especially in precision medicine and HEOR. To individual patients in order to dramatically improve outcomes and avoid 100Bs in the ineffective matching of treatments to patients and the downstream medical cost. New investors in this round are Celgene Corporation Alexandria Real Estat.

GNS Healthcare is a big data analytics company that focuses on discovering what works in the healthcare industry and for whom. GNS Healthcare accelerates the discovery and development of drugs to improve patient outcomes and significantly reduce total cost of patient care. In silico patient allows for clinical trials across cohorts of diverse patients to be conducted computationally by simulating disease progression and drug response at the individual patient level.

Our causal AI technology integrates and transforms a wide variety of patient data types into Gemini The in silico Patient which reveals the complex system of interactions underlying disease progression and drug response. Uncover why GNS Healthcare is the best company for you. Leading causal AI and simulations technology that differentiates GNS in the highly competitive marketplace.

We are a multi-disciplinary group of physicists actuaries geneticists engineers business people and computer scientists passionate about extracting the evidence of what works in healthcare and for whom. GNS Healthcare has raised a total of 773M in funding over 10 rounds. GNS Healthcare is funded by 12 investors.